Weed (BUDZ) Total Current Liabilities (2010 - 2026)
Weed (BUDZ) posted quarterly Total Current Liabilities of $1.4 million for Q1 2026, up 46.87% year-over-year from $921364.0 in Q1 2025, and up 8.41% quarter-over-quarter from $1.2 million in Q4 2025.
Weed (BUDZ) Total Current Liabilities (2010 - 2026) Analysis & Trends
Weed's Total Current Liabilities history runs 13 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 46.87% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 46.87% YoY), while the FY2025 annual figure was $1.2 million, up 30.11% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $1.4 million, up from $1.2 million in the prior quarter.
- The five-year high for Total Current Liabilities was $1.6 million in Q1 2022, with the low at $595779.0 in Q2 2024.
- The 5-year median for Total Current Liabilities is $1.1 million (2025), against an average of $1.1 million.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities tumbled 58.77% in 2024, then jumped 67.32% in 2025.
- Weed's Total Current Liabilities stood at $1.5 million in 2022, then slumped by 55.69% to $648753.0 in 2023, then jumped by 47.88% to $959372.0 in 2024, then soared by 30.11% to $1.2 million in 2025, then increased by 8.41% to $1.4 million in 2026.
- Business Quant data shows BUDZ's Total Current Liabilities at $1.4 million in Q1 2026, $1.2 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - | 1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 996,833.00 |
| Mar 31, 2025 | 921,364.00 |
| Dec 31, 2024 | 959,372.00 |
| Sep 30, 2024 | 685,045.00 |
| Jun 30, 2024 | 595,779.00 |
| Mar 31, 2024 | 596,333.00 |
| Dec 31, 2023 | 648,753.00 |
| Sep 30, 2023 | 654,081.00 |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 1.45 Mn |
| Jun 30, 2022 | 1.55 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 1.34 Mn |
| Sep 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 989,454.00 |